ARTH - Arch Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/20159/30/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development2,094.7951,683.2991,760.0371,477.479
Selling General and Administrative5,207.7534,367.4763,700.4773,134.285
Non Recurring----
Others----
Total Operating Expenses7,302.5486,050.7755,460.5144,611.764
Operating Income or Loss-7,302.548-6,050.775-5,460.514-4,611.764
Income from Continuing Operations
Total Other Income/Expenses Net-486.30858.4052,512.988-3,531.059
Earnings Before Interest and Taxes-7,302.548-6,050.775-5,460.514-4,611.764
Interest Expense-52.385-276.687-377.805-111.059
Income Before Tax-7,788.856-5,992.37-2,947.526-8,142.823
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-7,788.856-5,992.37-2,947.526-8,142.823
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-7,788.856-5,992.37-2,947.526-8,142.823
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-7,788.856-5,992.37-2,947.526-8,142.823